Valproic acid induced acute liver injury resulting in hepatic encephalopathy- a case report and literature review
Open Access
- 3 September 2018
- journal article
- review article
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 8 (5), 311-314
- https://doi.org/10.1080/20009666.2018.1514933
Abstract
Valproic acid (VPA) is a commonly used agent in the management of seizures and psychiatric disorders. Hyperammonemia is a common complication of VPA with 27.8% of patients having elevated levels – that is unrelated to hepatotoxicity and normal transaminases. Common side effects include obesity, insulin resistance, metabolic disorder and severe forms of hepatotoxicity. Other rare and idiosyncratic reactions have been reported, one of which is presented in our case. A 27-year old patient presented with hyperammonemia and encephalopathy as a consequence of idiosyncratic VPA reaction causing drug-induced liver injury (DILI) with severely elevated transaminases. DILI is commonly overlooked when investigating encephalopathy in the setting of VPA. Physicians should consider DILI in the context of hyperammonemia and transaminitis.Keywords
This publication has 30 references indexed in Scilit:
- Toxicity of valproic acid in isolated rat liver mitochondriaToxicology Mechanisms and Methods, 2013
- Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liverJournal of Hepatology, 2011
- Polymerase gamma Gene POLG Determines the Risk of Sodium Valproate-Induced Liver ToxicityHepatology, 2010
- Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranesFEBS Letters, 2008
- Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A reviewJournal of Inherited Metabolic Disease, 2008
- Valproate-associated Hyperammonemic EncephalopathyThe Journal of the American Board of Family Medicine, 2007
- Valproic Acid II: Effects on Oxidative Stress, Mitochondrial Membrane Potential, and Cytotoxicity in Glutathione-Depleted Rat HepatocytesToxicological Sciences, 2005
- The Role of Carnitine Supplementation during Valproic Acid TherapyAnnals of Pharmacotherapy, 2000
- Valproic AcidDrugs, 1994
- Hepatotoxicity to sodium valproate: a review.Gut, 1984